Monitoring compliance in the study by Pahor et al.
S
S
Leader
R
R
Mallick
D002121:Calcium Channel Blockers / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000188:drug therapy; D009369:Neoplasms / Q000209:etiology*; D012307:Risk Factors
D002121:Calcium Channel Blockers